Optimal response-adaptive allocation designs in phase III clinical trials: incorporating ethics in optimality (Q553031)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Optimal response-adaptive allocation designs in phase III clinical trials: incorporating ethics in optimality |
scientific article; zbMATH DE number 5932074
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Optimal response-adaptive allocation designs in phase III clinical trials: incorporating ethics in optimality |
scientific article; zbMATH DE number 5932074 |
Statements
Optimal response-adaptive allocation designs in phase III clinical trials: incorporating ethics in optimality (English)
0 references
26 July 2011
0 references
